45EGP
- Active ingredient
- glibenclamide(glyburide)+metformin
- Strength
- 5/500mg
- Form
- tablet
- Manufacturer
- future pharmaceutical industries (fpi)
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in severe renal impairment, metabolic acidosis, diabetic ketoacidosis, and hypersensitivity to either component.
Side effects
Hypoglycemia, nausea, diarrhea, abdominal discomfort, weight gain, and vitamin B12 deficiency may occur.
Warnings
May cause hypoglycemia and rare lactic acidosis. Renal function should be monitored.
How it works
Combines insulin secretion stimulation by glyburide with insulin sensitization and reduced hepatic glucose production by metformin.
Storage
Store at room temperature in a dry place.